Zhao, P
United States Food and Drug Administration
4 papers on CoChatORCID 0000-0001-6106-4620
Most cited papers
- Verified
Application of physiologically based pharmacokinetic (PBPK) modeling to support dose selection: report of an FDA public workshop on PBPK
Wagner, C., Zhao, P., Pan, Y., Hsu, V, Grillo, J., Huang, S., & Sinha, V (2015) · CPT: Pharmacometrics & Systems Pharmacology
Pharmaceutical studies and practicesStatistical Methods in Clinical Trials
Cited by 276
- Verified
Predicting the effect of cytochrome P450 inhibitors on substrate drugs: Analysis of physiologically based pharmacokinetic modeling submissions to the US Food and Drug Administration
Wagner, C., Pan, Y., Hsu, V., Grillo, J. A., Zhang, L., Reynolds, K. S., Sinha, V., & Zhao, P. (2015) · Clinical Pharmacokinetics
Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices
Cited by 148
- Verified
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients
Bulitta, J. B., Zhao, P., Arnold, R. D., Kessler, D. R., Daifuku, R., Pratt, J., Luciano, G., Hanauske, A.-R., Gelderblom, H., Awada, A., et al. (2009) · Cancer Chemotherapy and Pharmacology
Cancer Treatment and PharmacologyNanoparticle-Based Drug Delivery
Cited by 47
- Verified
Report from the EMA workshop on qualification and reporting of physiologically based pharmacokinetic (PBPK) modeling and simulation
Zhao, P. (2017) · CPT: Pharmacometrics & Systems Pharmacology
Pharmaceutical studies and practicesStatistical Methods in Clinical Trials
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free